scholarly journals Trends in mumps incidence and first dosage of MMR vaccine coverage in Montenegro from 2009 to 2018

2020 ◽  
Vol 49 (1) ◽  
pp. 15-23
Author(s):  
Aleksandar Obradović ◽  
Sandra Šipetić-Grujičić
Keyword(s):  
Vaccine Coverage ◽  
Mmr Vaccine

scholarly journals Perspectives on the Measles, Mumps and Rubella Vaccination among Somali Mothers in Stockholm

2018 ◽  
Vol 15 (11) ◽  
pp. 2428 ◽  
Author(s):  
Asha Jama ◽  
Mona Ali ◽  
Ann Lindstrand ◽  
Robb Butler ◽  
Asli Kulane
Keyword(s):  
Vaccination Coverage ◽  
Perceived Risk ◽  
Positive Impact ◽  
Vaccine Coverage ◽  
Qualitative Content Analysis ◽  
Vaccine Safety ◽  
Snowball Sampling ◽  
Mmr Vaccine ◽  
Rubella Vaccination ◽  
Depth Interviews

Background: Vaccination hesitancy and skepticism among parents hinders progress in achieving full vaccination coverage. Swedish measles, mumps and rubella (MMR) vaccine coverage is high however some areas with low vaccination coverage risk outbreaks. This study aimed to explore factors influencing the decision of Somali parents living in the Rinkeby and Tensta districts of Stockholm, Sweden, on whether or not to vaccinate their children with the measles, mumps and rubella (MMR) vaccine. Method: Participants were 13 mothers of at least one child aged 18 months to 5 years, who were recruited using snowball sampling. In-depth interviews were conducted in Somali and Swedish languages and the data generated was analysed using qualitative content analysis. Both written and verbal informed consent were obtained from participants. Results: Seven of the mothers had not vaccinated their youngest child at the time of the study and decided to postpone the vaccination until their child became older (delayers). The other six mothers had vaccinated their child for MMR at the appointed time (timely vaccinators). The analysis of the data revealed two main themes: (1) barriers to vaccinate on time, included issues surrounding fear of the child not speaking and unpleasant encounters with nurses and (2) facilitating factors to vaccinate on time, included heeding vaccinating parents’ advice, trust in nurses and trust in God. The mothers who had vaccinated their children had a positive impact in influencing other mothers to also vaccinate. Conclusions: Fear, based on the perceived risk that vaccination will lead to autism, among Somali mothers in Tensta and Rinkeby is evident and influenced by the opinions of friends and relatives. Child Healthcare Center nurses are important in the decision-making process regarding acceptance of MMR vaccination. There is a need to address mothers’ concerns regarding vaccine safety while improving the approach of nurses as they address these concerns.

Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations?

2012 ◽  
Vol 141 (3) ◽  
pp. 651-666 ◽  
Author(s):  
J. ERIKSEN ◽  
I. DAVIDKIN ◽  
G. KAFATOS ◽  
N. ANDREWS ◽  
C. BARBARA ◽  
...  
Keyword(s):  
Odds Ratio ◽  
Vaccine Coverage ◽  
International Comparisons ◽  
Igg Antibodies ◽  
Multivariable Model ◽  
Mmr Vaccine ◽  
High Coverage ◽  
Vaccination Strategies ◽  
Seroprevalence Data ◽  
Antibody Titres

SUMMARYMumps outbreaks have recently been recorded in a number of highly vaccinated populations. We related seroprevalence, epidemiological and vaccination data from 18 European countries participating in The European Sero-Epidemiology Network (ESEN) to their risk of mumps outbreaks in order to inform vaccination strategies. Samples from national population serum banks were collected, tested for mumps IgG antibodies and standardized for international comparisons. A comparative analysis between countries was undertaken using age-specific mumps seroprevalence data and information on reported mumps incidence, vaccine strains, vaccination programmes and vaccine coverage 5–12 years after sera collection. Mean geometric mumps antibody titres were lower in mumps outbreak countries [odds ratio (OR) 0·09, 95% confidence interval (CI) 0·01–0·71)]. MMR1 vaccine coverage ⩾95% remained protective in a multivariable model (P < 0·001), as did an interval of 4–8 years between doses (OR 0·08, 95% CI 0·01–0·85). Preventing outbreaks and controlling mumps probably requires several elements, including high-coverage vaccination programmes with MMR vaccine with 4–8 years between doses.

scholarly journals Annual Immunisation Coverage Report 2016

2019 ◽  
Vol 43 ◽  
Author(s):  
Brynley Hull ◽  
Alexandra Hendry ◽  
Aditi Dey ◽  
Frank Beard ◽  
Julia Brotherton ◽  
...  
Keyword(s):  
Vaccine Coverage ◽  
Hpv Vaccination ◽  
Immunisation Coverage ◽  
Mmr Vaccine ◽  
Age Assessment ◽  
Quarterly Data ◽  
Percentage Points ◽  
National Human ◽  
Indigenous Children ◽  
Data Point

This tenth annual immunisation coverage report shows data for the calendar year 2016 derived from the Australian Immunisation Register (AIR) and the National Human Papillomavirus (HPV) Vaccination Program Register. After a decade of being largely stable at around 90%, ‘fully immunised’ coverage at the 12-month assessment age increased in 2016 to reach 93.7% for the age assessment quarterly data point in December 2016, similar to the 93.4% for the age assessment quarterly data point in December 2016 for 60 months of age. Implementation of the ‘No Jab No Pay’ policy may have contributed to these increases. While ‘fully immunised’ coverage at the 24-month age assessment milestone decreased marginally from 90.8%, in December 2015, to 89.6% for the age assessment quarterly data point in December 2016, this was likely due to the assessment algorithm being amended in December 2016 to include four doses of DTPa vaccine instead of three, following reintroduction of the 18-month booster dose. Among Indigenous children, the gap in coverage assessed at 12 months of age decreased fourfold, from 6.7 percentage points in March 2013 to only 1.7 percentage points lower than non-Indigenous children in December 2016. Since late 2012, ‘fully immunised’ coverage among Indigenous children at 60 months of age has been higher than for non-Indigenous children. Vaccine coverage for the nationally funded seasonal influenza vaccine program for Indigenous children aged 6 months to <5 years, which commenced in 2015, remained suboptimal nationally in 2016 at 11.6%. Changes in MMR coverage in adolescents were evaluated for the first time. Of the 411,157 ten- to nineteen-year-olds who were not recorded as receiving a second dose of MMR vaccine by 31 December 2015, 43,103 (10.5%) of them had received it by the end of 2016. Many of these catch-up doses are likely to have been administered as a result of the introduction on 1 January 2016 of the Australian Government’s ‘No Jab No Pay’ policy. In 2016, 78.6% of girls aged 15 years had three documented doses of HPV vaccine (jurisdictional range 67.8–82.9%), whereas 72.9% of boys (up from 67.1 % in 2015) had received three doses.

scholarly journals Preventing congenital rubella infection in the European Region of WHO: 2010 target

2004 ◽  
Vol 9 (4) ◽  
pp. 3-4 ◽  
Author(s):  
J. S. Spika ◽  
F X Hanon ◽  
S Wassilak ◽  
R G Pebody ◽  
N Emiroglu
Keyword(s):  
Vaccine Coverage ◽  
Policy Decision ◽  
World Health Organisation ◽  
Congenital Rubella Syndrome ◽  
World Health ◽  
Measles Vaccine ◽  
Mmr Vaccine ◽  
Regional Office ◽  
Rubella Infection ◽  
Congenital Rubella

The World Health Organisation (WHO) Regional Office for Europe has recently published a strategic plan and surveillance guidelines for measles and congenital rubella infection. The strategy prioritises measles control activities but encourages the introduction of rubella vaccine when measles vaccine coverage has reached &gt;90 %; although, many western European countries with suboptimal measles vaccine coverage are already using the combined measles, mumps and rubella (MMR) vaccine. Women in these countries may have an especially high risk of having an infant with congenital rubella syndrome. WHO is seeking to improve the surveillance for rubella and congenital rubella syndrome as a means to obtain better information on the burden of these diseases and engage policy decision makers in the need to support the WHO European Region's strategies for rubella.

scholarly journals Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak—Iowa, 2015–2016

2018 ◽  
Vol 5 (10) ◽  
Author(s):  
Mona Marin ◽  
Tricia L Kitzmann ◽  
Lisa James ◽  
Patricia Quinlisk ◽  
Wade K Aldous ◽  
...  
Keyword(s):  
Public Health ◽  
Vaccine Coverage ◽  
The United States ◽  
Mmr Vaccine ◽  
Public Health Response ◽  
University Of Iowa ◽  
Outbreak Control ◽  
Response Planning ◽  
Health Response ◽  
The University

Abstract Background The United States is experiencing mumps outbreaks in settings with high 2-dose measles-mumps-rubella (MMR) vaccine coverage, mainly universities. The economic impact of mumps outbreaks on public health systems is largely unknown. During a 2015–2016 mumps outbreak at the University of Iowa, we estimated the cost of public health response that included a third dose of MMR vaccine. Methods Data on activities performed, personnel hours spent, MMR vaccine doses administered, miles traveled, hourly earnings, and unitary costs were collected using a customized data tool. These data were then used to calculate associated costs. Results Approximately 6300 hours of personnel time were required from state and local public health institutions and the university, including for vaccination and laboratory work. Among activities demanding time were case/contact investigation (36%), response planning/coordination (20%), and specimen testing and report preparation (13% each). A total of 4736 MMR doses were administered and 1920 miles traveled. The total cost was &gt;$649 000, roughly equally distributed between standard outbreak control activities and third-dose MMR vaccination (55% and 45%, respectively). Conclusions Public health response to the mumps outbreak at the University of Iowa required important amounts of personnel time and other resources. Associated costs were sizable enough to affect other public health activities.

scholarly journals Epidemiology of measles, mumps and rubella in Italy

2002 ◽  
Vol 129 (3) ◽  
pp. 543-550 ◽  
Author(s):  
G. GABUTTI ◽  
M. C. ROTA ◽  
S. SALMASO ◽  
B. M. BRUZZONE ◽  
A. BELLA ◽  
...  
Keyword(s):  
Vaccine Coverage ◽  
Age Groups ◽  
Progressive Increase ◽  
Childhood Immunization ◽  
Mmr Vaccine ◽  
Seroprevalence Data ◽  
The Mean ◽  
European Standards ◽  
Serological Data ◽  
Vaccination Campaigns

A serosurvey for measles, mumps and rubella was conducted in Italy; incidence based on statutory notifications over the last three decades was also calculated. In Italy the diseases followed an endemic–epidemic pattern, with an incidence peak every 2–4 years, and had a limited reduction of incidence attributable to childhood immunization. Lower notification rates were observed in the Southern regions. This is possibly related to greater under notification in the South and is confirmed by our seroprevalence data. Incidence of measles and rubella and proportion of cases among young adults increased significantly in the three decades considered, but not for mumps. Serological data confirmed that these infections are still very frequent in Italy, without significant geographic variation in the country. In the age groups 2–4 and 5–9 years the percentage of individuals still susceptible to each virus was higher than 30%. The proportion of susceptible subjects older than 15 years was similar for the three infections (6·1, 11·7 and 8·8% for measles, mumps and rubella, respectively). The low vaccine coverage for rubella and measles in Italy has so far only partially affected the occurrence of the diseases. No impact of mumps vaccination is visible. The average number of deaths, for each disease, has decreased during the three study periods. Today the priority in Italy is to halt the progressive increase of the mean age of acquisition of the three infections, to eliminate differences in coverage among regions and to conform to European standards. This will be achieved through a combination of increasing MMR vaccine coverage before 2 years of age, implementing vaccination campaigns for low seroprevalence age groups, and/or introducing a second dose of MMR, depending on the level of current MMR coverage.

scholarly journals An Insight into the Immunization Coverage for Combined Vaccines in Albania

2017 ◽  
Vol 13 (3) ◽  
pp. 33
Author(s):  
Eftiola Pojani ◽  
Erida Nelaj ◽  
Alban Ylli
Keyword(s):  
Vaccination Coverage ◽  
Vaccine Coverage ◽  
Immunization Coverage ◽  
Mmr Vaccine ◽  
Country Level ◽  
The Stability ◽  
Combined Vaccine ◽  
Very High ◽  
Insight Into ◽  
Dose Vaccine

We aim to Provide facts about the vaccination coverage for combined vaccines such as MMR (Measles, Mumps and Rubella) and DTP (Diphtheria, Tetanus, Pertussis) containing vaccines in use in Albania during the last 10 years, in order to confirm the stability of immunization program. One of the reasons for coverage improvement is the use of one or two-dose vials for the administration of MMR vaccine, enabling the vaccination of children at any time, without the need of gathering them on certain days when the multi-dose vaccine vials are opened. In the last three years, according to WHO recommendations, it was noted that vaccination coverage with three doses containing DTP is at sustainable levels, always above 95%, but for our country this value goes sometimes above 98%. As for the use of pentavalent vaccine, from 2008, DTP-HepB-Hib, also the coverage of Hepatitis b vaccine is always at upper levels due to its use on 5 in 1 combination. The application of this vaccine was associated with the use of one dose vial administration, therefore one vaccine to a child. Immunization coverage for vaccines with measles component remains at very high levels for both doses of vaccine, more then 95%. Immunization coverage for vaccines with DTP component exceeds 95% rate at country level, for each district it exceeds 95% and it reaches the value of 98.5% for the last two years. During the last years the vaccine coverage is increased significantly as a result of using combined vaccine of DTP-HepB -Hib. The use of one dose vials has played an important role on sustaininig and increasing vaccination coverage.

Epidemiological and molecular assessment of a measles outbreak in a highly vaccinated population of northeast Italy

2011 ◽  
Vol 139 (11) ◽  
pp. 1727-1733 ◽  
Author(s):  
P. D'AGARO ◽  
G. DAL MOLIN ◽  
T. GALLO ◽  
T. ROSSI ◽  
D. SANTON ◽  
...  
Keyword(s):  
Measles Virus ◽  
Vaccine Coverage ◽  
Point Of View ◽  
Mmr Vaccine ◽  
Measles Outbreak ◽  
Northeastern Italy ◽  
Molecular Assessment ◽  
Measles Outbreaks ◽  
The City ◽  
Target Children

SUMMARYTwo distinct measles outbreaks, unrelated from the epidemiological point of view but caused by genetically related strains, occurred in the Friuli Venezia Giulia region of northeastern Italy. Forty-two cases were reported during the period April–May 2008. In the first outbreak the index case was a teacher who introduced the virus into the Pordenone area, involving eight adolescents and young adults. The other concomitant outbreak occurred in the city of Trieste with 33 cases. The containment of the epidemics can be explained by the high MMR vaccine coverage in an area where the first dose was delivered to 93·4% and the second dose to 88·3% of the target children. Phylogenetic analysis of 14 measles virus strains showed that they belonged to a unique D4 genotype indistinguishable from the MVs/Enfield.GBR/14.07 strain, probably introduced from areas (i.e. Piedmont and Germany) where this genotype was present or had recently caused a large epidemic.

Sign in / Sign up

Export Citation Format

Share Document